We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Tadalafil versus tamsulosin as combination therapy with 5-alpha reductase inhibitors in benign prostatic hyperplasia, urinary and sexual outcomes

    Purpose

    To compare the urological and sexual outcomes of using either tamsulosin/finateride or tadalafil/finasteride as combination therapies in...

    Ahmed Tawfik, Mohammed Abo-Elenen, ... Ayman Ghoneim in World Journal of Urology
    Article 03 February 2024
  2. Thrombotic risk of platinum combination chemotherapy with and without immune checkpoint inhibitors for advanced non-small cell lung cancer: a nationwide inpatient database study

    Objectives

    To determine the associated thromboembolism risk with adding immune checkpoint inhibitors (ICI) to platinum combination chemotherapy...

    Chikako Iwai, Taisuke Jo, ... Hideo Yasunaga in Cancer Immunology, Immunotherapy
    Article Open access 04 August 2023
  3. Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study

    Background

    There are evidences showing that sitagliptin and spironolactone can potentially improve the clinical outcomes of COVID-19 cases. In this...

    M. A. Davarpanah, R. Adatorwovor, ... K. Asadipooya in Journal of Endocrinological Investigation
    Article 24 June 2023
  4. Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies

    Combination therapy has birthed improved treatment possibilities for a number of complex and degenerative diseases in the world, which include...

    Bidemi Emmanuel Ekundayo, Tajudeen Olabisi Obafemi, ... Babatunji Emmanuel Oyinloye in Comparative Clinical Pathology
    Article 09 June 2023
  5. Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients

    Purpose

    A brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination (BBFC) was recently approved for glaucoma and ocular hypertension treatment...

    Rei Sakata, Shiro Mizoue, ... Makoto Aihara in Japanese Journal of Ophthalmology
    Article 19 August 2023
  6. Effect of bone marrow aspiration concentrate and platelet-rich plasma combination in anterior cruciate ligament reconstruction: a randomized, prospective, double-blinded study

    Background

    The effect of bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP) combination in enhancing graft maturation and...

    Yu-Chuan Lin, Yu-Jen Chen, ... Cheng-Chang Lu in Journal of Orthopaedic Surgery and Research
    Article Open access 03 January 2024
  7. AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

    Background

    The efficacy of monotherapy of AMG-510 is limited. This study explored whether the AMG-510 and cisplatin combination increases the...

    Lei-Lei Wu, Wen-Mei Jiang, ... Dong **e in Discover Oncology
    Article Open access 07 June 2023
  8. Clinical observation of acupuncture with host-guest combination using Yuan-Primordial and Luo-Connecting points plus Tuina for the third lumbar transverse process syndrome

    Objective

    To observe the effects of acupuncture at Yuan-Primordial and Luo-Connecting points by host-guest combination plus Tuina (Chinese therapeutic...

    Zhiou Cao, Yuxin Guo, ... Miao He in Journal of Acupuncture and Tuina Science
    Article 19 August 2023
  9. A Novel Combination Strategy of Ultrasound-Guided Percutaneous Radiofrequency Ablation and Corticosteroid Injection for Treating Recalcitrant Plantar Fasciitis: A Retrospective Comparison Study

    Introduction

    The best treatment yielding clinical benefits was still equivocal and controversial for the treatment of recalcitrant plantar fasciitis...

    Yinfeng Zheng, Tianyi Wang, ... Jian Li in Pain and Therapy
    Article Open access 03 July 2024
  10. Sustainability of peritoneal dialysis and renal function with proactive combination therapy

    Most combined peritoneal dialysis and hemodialysis therapies are used to compensate for the lack of dialysis volume and efficiency in pre-started...

    Kei Nagai, Atsushi Ueda in Journal of Artificial Organs
    Article 06 December 2022
  11. Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine

    Introduction

    Multidrug regimens for glaucoma treatment often result in adherence issues due to inconvenience; these issues may be improved with...

    Hidenobu Tanihara, Tetsuya Yamamoto, ... Masashi Takat in Advances in Therapy
    Article Open access 18 June 2023
  12. Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials

    Background

    Exercise, particularly resistance exercise, is beneficial for sarcopenia in patients with liver cirrhosis. However, the effects of exercise...

    Takumi Kawaguchi, Atsushi Kawaguchi, ... Sachiyo Yoshio in Journal of Gastroenterology
    Article 30 December 2023
  13. Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia

    Purpose

    To assess adherence to combination therapy comprising α-adrenergic blocker (AB) and 5α-reductase inhibitor (5ARI) for benign prostatic...

    Jae Duck Choi, Tag Keun Yoo, ... Jun Ho Lee in International Urology and Nephrology
    Article 10 February 2023
  14. Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction

    Purpose of Review

    The number of medications prescribed to patients has been progressively increasing, primarily driven by cardioprotective...

    **wook Park, Chien-Wen Yang, ... Sandeep Aggarwal in Current Cardiology Reports
    Article 22 November 2023
  15. Prognostic impact of the combination of p16INK4a, p21 and Immunoscore in rectal cancer

    Background

    The association between p16 INK4a and p21, a marker of cellular senescence, and the Immunoscore, an immunological prognostic indicator, in...

    Toshihiro Nakao, Mitsuo Shimada, ... Toshiaki Yoshimoto in International Journal of Clinical Oncology
    Article 19 June 2024
  16. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov

    Combination therapies have taken center stage for cancer treatment, however, there is a lack of a comprehensive portrait to quantitatively map the...

    **g Yang, Heming Kang, ... Yuanjia Hu in Discover Oncology
    Article Open access 21 August 2023
  17. Combination therapy for kidney disease in people with diabetes mellitus

    Diabetic kidney disease (DKD), defined as co-existing diabetes and chronic kidney disease in the absence of other clear causes of kidney injury,...

    Daniël H. van Raalte, Petter Bjornstad, ... Hiddo J. L. Heerspink in Nature Reviews Nephrology
    Article 03 April 2024
  18. Evaluation of Bruton tyrosine kinase inhibitors monotherapy and combination therapy in lymphocytic leukemia

    BTKi is an effective treatment in chronic lymphocytic leukemia. However, head-to-head clinical trials between BTKi are rare. To explore...

    **angxing Liu, Binyi Hu, ... Yi Fang in Clinical and Experimental Medicine
    Article 13 October 2023
  19. Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

    Background

    Osimertinib has become standard care for epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC) patients...

    Ruoshuang Han, Haoyue Guo, ... Caicun Zhou in BMC Medicine
    Article Open access 24 April 2024
  20. Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy

    Rituximab (RTX) has been the first option in idiopathic membranous nephropathy (IMN). However, the clinical effect was not very satisfactory. This...

    Qiqi Ma, Manna Li, Gaosi Xu in Clinical and Experimental Medicine
    Article 09 September 2023
Did you find what you were looking for? Share feedback.